Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2017 1
2019 1
2020 4
2021 6
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean m kazemi (269 results)?
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
METHODS: In this randomized, placebo-controlled trial conducted at 344 sites across 28 countries, we evaluated efpeglenatide in participants with type 2 diabetes and either a history of cardiovascular disease or current kidney disease (defined as an estimated glomerular filtratio …
METHODS: In this randomized, placebo-controlled trial conducted at 344 sites across 28 countries, we evaluated efpeglenatide in participants …
Smartphone apps to help children and adolescents with cancer and their families: a scoping review.
Mehdizadeh H, Asadi F, Mehrvar A, Nazemi E, Emami H. Mehdizadeh H, et al. Acta Oncol. 2019 Jul;58(7):1003-1014. doi: 10.1080/0284186X.2019.1588474. Epub 2019 Mar 27. Acta Oncol. 2019. PMID: 30915872 Review.
Conclusions: Due to the easy access to smartphones without a costly infrastructure compared to landline phones, the use of mobile health (m-Health) has become a suitable method of providing healthcare services, especially for cancer. ...Thus, healthcare policy-makers in de …
Conclusions: Due to the easy access to smartphones without a costly infrastructure compared to landline phones, the use of mobile health ( …
Level of obesity is directly associated with complications following arthroscopic rotator cuff repair.
Kashanchi KI, Nazemi AK, Komatsu DE, Wang ED. Kashanchi KI, et al. J Shoulder Elbow Surg. 2021 Jul;30(7):1581-1587. doi: 10.1016/j.jse.2020.09.029. Epub 2020 Oct 22. J Shoulder Elbow Surg. 2021. PMID: 33536124

Patients were stratified into 3 cohorts according to their body mass index (BMI). Patients with a BMI < 30 kg/m(2) were placed in the non-obese cohort, patients with a BMI between 30 and 40 kg/m(2) were placed in the obese cohort, and patients with a BMI > 40

…

Patients were stratified into 3 cohorts according to their body mass index (BMI). Patients with a BMI < 30 kg/m(2) were placed in

…
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Wright KD, Yao X, London WB, Kao PC, Gore L, Hunger S, Geyer R, Cohen KJ, Allen JC, Katzenstein HM, Smith A, Boklan J, Nazemi K, Trippett T, Karajannis M, Herzog C, Destefano J, Direnzo J, Pietrantonio J, Greenspan L, Cassidy D, Schissel D, Perentesis J, Basu M, Mizuno T, Vinks AA, Prabhu SP, Chi SN, Kieran MW. Wright KD, et al. Pediatr Blood Cancer. 2021 Feb;68(2):e28787. doi: 10.1002/pbc.28787. Epub 2020 Nov 2. Pediatr Blood Cancer. 2021. PMID: 33140540 Free PMC article. Clinical Trial.
BACKGROUND: To evaluate efficacy, pharmacokinetics (PK) and pharmacodynamics of single-agent everolimus in pediatric patients with radiographically progressive low-grade glioma (LGG). METHODS: Everolimus was administered at 5 mg/m(2) once daily as a tablet or liquid for a …
BACKGROUND: To evaluate efficacy, pharmacokinetics (PK) and pharmacodynamics of single-agent everolimus in pediatric patients with radiograp …
Safflower-based biorefinery producing a broad spectrum of biofuels and biochemicals: A life cycle assessment perspective.
Hosseinzadeh-Bandbafha H, Nazemi F, Khounani Z, Ghanavati H, Shafiei M, Karimi K, Lam SS, Aghbashlo M, Tabatabaei M. Hosseinzadeh-Bandbafha H, et al. Sci Total Environ. 2022 Jan 1;802:149842. doi: 10.1016/j.scitotenv.2021.149842. Epub 2021 Aug 21. Sci Total Environ. 2022. PMID: 34455274
Based on the obtained results, safflower production and its processing into 1 MJ bioethanol under the safflower-based biorefinery led to damage of 2.23E-07 disability-adjusted life years (DALY), 2.35E-02 potentially disappeared fraction (PDF)*m(2)*yr, 4.76E-01 kg CO(2) eq. …
Based on the obtained results, safflower production and its processing into 1 MJ bioethanol under the safflower-based biorefinery led to dam …
Molecular Networking-Guided Isolation of New Etzionin-Type Diketopiperazine Hydroxamates from the Persian Gulf Sponge Cliona celata.
Kouchaksaraee RM, Li F, Nazemi M, Farimani MM, Tasdemir D. Kouchaksaraee RM, et al. Mar Drugs. 2021 Jul 31;19(8):439. doi: 10.3390/md19080439. Mar Drugs. 2021. PMID: 34436278 Free PMC article.
Compounds 1 and 2 exhibited broad antibacterial, antifungal, and anticancer activities, with IC(50) values ranging from 19.6 to 159.1 M. This is the first study investigating the chemical constituents of a C. celata specimen from the Persian Gulf. ...
Compounds 1 and 2 exhibited broad antibacterial, antifungal, and anticancer activities, with IC(50) values ranging from 19.6 to 159.1 M …
17 results